This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kessler TM et al. (2005) Botulinum A toxin injections into the detrusor: an effective treatment in idiopathic and neurogenic detrusor overactivity? Neurourol Urodyn 24: 231–236
Smith CP et al. (2005) Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65: 37–41
Schulte-Baukloh H et al. (2005) Botulinum-A toxin for treatment of overactive bladder without detrusor overactivity: urodynamic outcome and patient satisfaction. Urology 66: 82–87
Rapp DE et al. (2004) Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology 63: 1071–1075
Khera M et al. (2004) Botulinum toxin A inhibits ATP release from bladder urothelium after chronic spinal cord injury. Neurochem Int 45: 987–993
Apostolidis A et al. (2005) Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol 174: 977–982
Acknowledgements
The synopsis was written by Sandra Ford, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has been a Consultant, Investigator, and Research Grant Recipient for Allergan Inc., Irvine, CA.
Rights and permissions
About this article
Cite this article
Smith, C. Botulinum toxin for overactive bladder: reaching a happy median. Nat Rev Urol 3, 128–129 (2006). https://doi.org/10.1038/ncpuro0427
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/ncpuro0427